Elevance Health, Inc. (ELV), on Wednesday, reported a higher fourth quarter net income compared with the previous year and issued full year 2026 guidance.
In the pre-market trading, Elevance Health is 6.11% lesser at $303.26 on the New York Stock Exchange.
For the fourth quarter, net income attributable to shareholders increased to $547 million from $418 million in the previous year.
Earnings per share were $2.47 versus $1.81 last year.
On the adjusted basis, net income to shareholders declined to $739 million from $747 million in the previous year.
Adjusted earnings per share were $3.33 versus $3.23 last year.
On average, twenty analysts had expected the company to report $3.09 per share. Analysts' estimates typically exclude special items.
Operating revenue jumped to $49.31 billion from $44.99 billion in the same period last year.
Revenue increased to $49.75 billion from $45.44 billion in the previous year.
Looking ahead, the company expected full-year 2026 operating revenue to decline in the low single digits.
Adjusted operating gain is expected to be at least $6.8 billion for the full year 2026.
Earnings per share for the full year 2026 is anticipated to be at least $22.30 and adjusted earnings per share to be at least $25.50.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.